Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Transcriptomic Profiling of Dromedary Camels Immunised with a MERS Vaccine Candidate

Version 1 : Received: 11 April 2021 / Approved: 22 April 2021 / Online: 22 April 2021 (10:34:12 CEST)

How to cite: Hala, S.; Ribeca, P.; Aljami, H.A.; Qasim, I.; Gilbert, S.C.; Alharbi, N.K. Transcriptomic Profiling of Dromedary Camels Immunised with a MERS Vaccine Candidate. Preprints 2021, 2021040605 (doi: 10.20944/preprints202104.0605.v1). Hala, S.; Ribeca, P.; Aljami, H.A.; Qasim, I.; Gilbert, S.C.; Alharbi, N.K. Transcriptomic Profiling of Dromedary Camels Immunised with a MERS Vaccine Candidate. Preprints 2021, 2021040605 (doi: 10.20944/preprints202104.0605.v1).

Abstract

Middle East Respiratory Syndrome coronavirus (MERS-CoV) infects dromedary camels and zoonotically infects humans, causing a respiratory disease with severe pneumonia and death. With no approved antiviral or vaccine interventions for MERS, vaccines are being developed for camels to prevent virus transmission into humans. We have previously developed a chimpanzee adenoviral vector-based vaccine for MERS-CoV (ChAdOx1 MERS) and reported its strong humoral immunogenicity in dromedary camels. Here, we looked back at total RNA isolated from three immunised dromedaries pre and post-vaccination during the first day; and performed RNA sequencing and bioinformatic analysis in order to shed light on the molecular immune responses following a ChAdOx1 MERS vaccination. Our finding shows that a number of transcripts were differentially regulated as an effect of the vaccination, including genes that are involved in innate and adaptive immunity, such as type I and II interferon responses. The camel Bcl-3 and Bcl-6 transcripts were significantly upregulated, indicating a strong activation of Tfh cells, B cell, and NF-kB pathways. In conclusion, this study gives an overall view of the first changes in the immune transcriptome of dromedaries after vaccination; it supports the potency of ChAdOx1 MERS as a potential camel vaccine to block transmission and prevent new human cases and outbreaks.

Subject Areas

Transcriptome; gene expression; camel; MERS-CoV; vaccine; immunogenicity

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.